74. European Commission. Antitrust: Commission fines Lundbeck and other pharma companies for delaying market entry of generic medicines. Press release. 2013 June 19.
75. Abelson R. Whistle-blower suit says device maker generously rewards doctors. New York Times. 2006 Jan 24.
76. Poses R.M. Medtronic settles, yet again. Blog post. Health Care Renewal. 2011 Dec 15. Available online at: http://hcrenewal.blogspot.co.nz/2011/12/medtronic-settles-yet-again.html (accessed 10 July 2013).
77. Tanne J.H. US companies are fined for payments to surgeons. BMJ. 2007; 335: 1065.
78. Harris G., Pear R. Drug maker’s efforts to compete in lucrative insulin market are under scrutiny. New York Times. 2006 Jan 28.
79. Abelson R. How Schering manipulated drug prices and Medicaid. New York Times. 2004 July 31.
80. Harris G. Drug makers settled 7 suits by whistle-blowers, group says. New York Times. 2003 Nov 6.
81. OxyContin’s deception costs firm $634M. CBS News. 2007 May 10.
82. Zee A van. The promotion and marketing of OxyContin: commercial triumph, public health tragedy. Am J Publ Health. 2009; 99: 221–7.
83. Wordsworth M. Deadly epidemic fears over common painkiller. ABC News. 2012 Nov 14.
84. Kendall B. Court backs crackdown on drug officials. Wall Street Journal. 2010 July 27.
85. Tansey B. Huge penalty in drug fraud: Pfizer settles felony case in Neurontin off-label promotion. San Francisco Chronicle. 2004 May 14.
86. Collier J. Big pharma and the UK government. Lancet. 2006; 367: 97–8.
87. Ferner R.E. The influence of big pharma. BMJ. 2005; 330: 857–8.
88. Smith R. Curbing the influence of the drug industry: a British view. PLoS Med. 2005; 2: e241.
89. Moynihan R. Officials reject claims of drug industry’s influence. BMJ. 2004; 329: 641.
90. Goldacre B. Bad Pharma. London: Fourth Estate; 2012.
91. Free Online Law Dictionary. Organized crime. Available online at: http://legal-dictionary.thefreedictionary.com/Organized+Crime (accessed 2 December 2012).
92. Peter Rost. Blog. Available online at: http://peterrost.blogspot.dk (accessed 26 June 2012).
93. Almashat S., Preston C., Waterman T., et al. Rapidly increasing criminal and civil monetary penalties against the pharmaceutical industry: 1991 to 2010. Public Citizen. 2010 Dec 16.
94. Almashat S., Wolfe S. Pharmaceutical industry criminal and civil penalties: an update. Public Citizen. 2012 Sept 27.
